FDA NDC Directory · JSON-LD · Markdown

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

NDC 35573-464 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerBurel Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA212037
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsAMPHETAMINE ASPARTATE MONOHYDRATE (1.25 mg/1)
AMPHETAMINE SULFATE (1.25 mg/1)
DEXTROAMPHETAMINE SACCHARATE (1.25 mg/1)
DEXTROAMPHETAMINE SULFATE (1.25 mg/1)
Marketing started20191216
Marketing ended20280229
Package count1

External sources

Source: openFDA. Public-domain (CC0).